Form 4: Semler Scientific CEO Exercises Options, Sells Shares
Insider Transaction Report
Semler Scientific's CEO, Douglas Murphy-Chutorian, exercised stock options and subsequently sold a portion of the acquired shares to cover costs, while also gifting shares to a family trust.
Summary
- Douglas Murphy-Chutorian, CEO and Director of Semler Scientific, Inc. (SMLR), reported transactions on August 25, 2025.
- Exercised options to acquire 60,000 shares of common stock at an exercise price of $2.56 per share.
- Sold 28,604 shares of common stock at a weighted average price of $30.54 per share to cover the exercise price and withholding taxes.
- Disposed of 31,396 shares of common stock via gift at $0.
- Acquired 31,396 shares of common stock via gift at $0, held indirectly in a family trust.
- Following these transactions, direct beneficial ownership is 31,396 shares, and indirect beneficial ownership through a family trust is 186,709 shares.
Sentiment
Score: 6
Explanation: The transactions are routine for an executive exercising options and covering costs. While there's a sale, it's offset by the option exercise and a portion of shares remaining, indicating a neutral to slightly positive sentiment as the executive is realizing value from their compensation.
Positives
- CEO exercised options, indicating a realization of value from previously granted equity.
- The exercise price of $2.56 is significantly lower than the sale price of $30.54, demonstrating substantial in-the-money value for the options.
Negatives
- A significant number of shares (28,604) were sold by the CEO, which could be perceived as a reduction in direct ownership, although this was stated to cover exercise costs and taxes.
- A gift of 31,396 shares also reduced direct ownership.
Industry Context
This Form 4 filing reports routine insider transactions for an executive, which typically do not provide broader industry context.
Related Party Transactions
- Gift of 31,396 shares of common stock to a family trust where Dr. Murphy-Chutorian is a co-Trustee with his spouse, sharing voting and investment power.
Stakeholder Impact
- Shareholders: The sale of shares by the CEO could be viewed as a slight reduction in direct insider ownership, but the overall beneficial ownership (direct + indirect) remains substantial. The exercise of options indicates the CEO is realizing value from their compensation.
Key Dates
| Date | Description |
|---|---|
| 08/25/2025 | Date of stock option exercise, share sale, and gift transactions. |
| 12/31/2025 | Expiration date of the exercised stock option. |
| 08/26/2025 | Date the Form 4 was signed. |
Recommendation
holdThe filing details routine insider transactions involving the exercise of stock options and subsequent sale of shares to cover taxes and exercise costs, along with a gift to a family trust. These actions are typical for executives managing their equity compensation and do not inherently signal a change in the company's fundamental outlook or performance. Therefore, a 'hold' recommendation is appropriate as the filing does not provide new information to warrant a change in investment thesis.
Keywords
Semler Scientific, SMLR, Form 4, Insider Trading, Stock Options, CEO, Share Sale, Equity Compensation, Beneficial Ownership, Douglas Murphy-Chutorian
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.